glucagon is essential for alpha cell transdifferentiation and beta cell neogenesis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The interconversion of cell lineages via transdifferentiation is an adaptive mode of tissue regeneration and an appealing therapeutic target. However, its clinical exploitation is contingent upon the discovery of contextual regulators of cell fate acquisition and maintenance. In murine models of diabetes, glucagon-secreting alpha cells transdifferentiate into insulin-secreting beta cells following targeted beta cell depletion, regenerating the form and function of the pancreatic islet. However, the molecular triggers of this mode of regeneration are unknown. Here, using lineage-tracing assays in a transgenic zebrafish model of beta cell ablation, we demonstrate conserved plasticity of alpha cells during islet regeneration. In addition, we show that glucagon expression is upregulated after injury. Through gene knockdown and rescue approaches, we also find that peptides derived from the glucagon gene are necessary for alpha-to-beta cell fate switching. Importantly, whereas beta cell neogenesis was stimulated by glucose, alpha-to-beta cell conversion was not, suggesting that transdifferentiation is not mediated by glucagon/GLP-1 control of hepatic glucose production. Overall, this study supports the hypothesis that alpha cells are an endogenous reservoir of potential new beta cells. It further reveals that glucagon plays an important role in maintaining endocrine cell homeostasis through feedback mechanisms that govern cell fate stability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
Dor, Y., Brown, J., Martinez, O. I., & Melton, D. A. (2004) · Nature · doi:10.1038/nature02520 · Cited by 2,219 · cited 2×
“Proliferation of surviving β cells predominates after targeted ablation of 70-80% of β cells (Dor et al., 2004; Nir et al., 2007), while conversion of α or δ cells to β cells occurs only with extreme β cell loss (>99”
BackgroundConversion of adult pancreatic α-cells to β-cells after extreme β-cell loss
Thorel, F., Népote, V., Avril, I., Kohno, K., Desgraz, R., Chera, S., & Herrera, P. L. (2010) · Nature · doi:10.1038/nature08894 · Cited by 1,136 · cited 4×
“Third, spontaneous transdifferentiation of β cells from α or δ cells occurs in conditions of extreme β cell loss (Thorel et al., 2010; Chera et al., 2014).”
BackgroundInfluentialGlucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670 · cited 16×
“Arx is a potent reprogramming factor that is essential for α cell development and maintenance (Collombat et al., 2003, 2007; Courtney et al., 2013).”
BackgroundInfluentialRecovery from diabetes in mice by β cell regeneration
Nir, T., Melton, D. A., & Dor, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32959 · Cited by 595 · cited 1×
“Proliferation of surviving β cells predominates after targeted ablation of 70-80% of β cells (Dor et al., 2004; Nir et al., 2007), while conversion of α or δ cells to β cells occurs only with extreme β cell loss (>99”
BackgroundGelling, R. W., Du, X. Q., Dichmann, D. S., Rømer, J., Huang, H., Cui, L., Obici, S., Tang, B., Holst, J. J., Fledelius, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237106100 · Cited by 563
Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers
Chera, S., Baronnier, D., Ghila, L., Cigliola, V., Jensen, J. N., Gu, G., Furuyama, K., Thorel, F., Gribble, F. M., Reimann, F., et al. (2014) · Nature · doi:10.1038/nature13633 · Cited by 410 · cited 4×
“Third, spontaneous transdifferentiation of β cells from α or δ cells occurs in conditions of extreme β cell loss (Thorel et al., 2010; Chera et al., 2014).”
BackgroundInfluentialUpdate on Islet Transplantation
McCall, M., & James Shapiro, A. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007823 · Cited by 226
Cited by
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity
Li, J., Casteels, T., Frogne, T., Ingvorsen, C., Honoré, C., Courtney, M., Huber, K. V. M., Schmitner, N., Kimmel, R. A., Romanov, R. A., et al. (2017) · Cell · doi:10.1016/j.cell.2016.11.010 · Cited by 376
Zebrafish as a Model for Obesity and Diabetes
Zang, L., Maddison, L. A., & Chen, W. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00091 · Cited by 302
Augsornworawat, P., Maxwell, K. G., Velazco-Cruz, L., & Millman, J. R. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108067 · Cited by 200
Alpha cell dysfunction in type 1 diabetes
Yosten, G. L. C. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.001 · Cited by 62
Szlapinski, S. K., & Hill, D. J. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200320111209 · Cited by 56
Metadata
- Authors
- Ye, L., Robertson, M. A., Hesselson, D., Stainier, D. Y. R., & Anderson, R. M.
- Venue
- Development
- Publisher
- The Company of Biologists
- Published
- 2015-04-15
- Volume
- 142
- Issue
- 8
- Pages
- 1407-1417
- ISSN
- 0950-1991 (ISSN-L)
- 1477-9129
- OpenAlex
- W2162033174
- Cited by
- 139
- References
- 8
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: glucagon is essential for alpha cell transdifferentiation and beta cell neogenesis. https://app.cochat.ai/papers/10.1242/dev.117911
- The paper
- Ye, L., Robertson, M. A., Hesselson, D., Stainier, D. Y. R., & Anderson, R. M. (2015). glucagon is essential for alpha cell transdifferentiation and beta cell neogenesis. Development. https://doi.org/10.1242/dev.117911
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.